Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from XBiotech ( (XBIT) ).
XBiotech Inc. has appointed Dr. Tak W. Mak to its Board of Directors, filling an existing vacancy. Dr. Mak, a distinguished scientist known for his groundbreaking work in immunology, will serve until the next annual general meeting. His contributions to the field, including the identification of the immune checkpoint inhibitor CTLA-4, have significantly impacted oncology therapeutics. This appointment is expected to enhance XBiotech’s leadership and innovation in the industry.
More about XBiotech
YTD Price Performance: 2.25%
Average Trading Volume: 61,993
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $124.7M
Learn more about XBIT stock on TipRanks’ Stock Analysis page.